甲状腺功能减退伴发抑郁的脑多巴胺系统功能的初步研究
|
摘要
目的：了解不同剂量放射性131I诱导甲状腺功能减退大鼠抑郁行为及脑内多巴胺受体1表达情况。
方法：应用不同剂量（50μCi，100μCi，200μCi，400μCi）放射性131I处理健康Sprague-Dawley(SD)成年大鼠，获得成年甲状腺功能减退大鼠模型。于每两周测定血清T3，T4，TSH及体重，分别于第8周、12周行大鼠抑郁行为学实验：悬尾实验(Tail Suspension Test, TST)，强迫游泳实验(Forced Swim Test, FST)观察后处死，应用RT-PCR和Western blot方法观察脑纹状体D1DRmRNA及蛋白表达情况。
结果：1.50μCi放射性131I并不能成功获得甲状腺功能减退大鼠模型，而100μCi以上放射性131I可以诱导成功建立甲状腺功能减退大鼠模型。2.甲状腺功能减退大鼠抑郁行为学实验(TST和FST)表明甲状腺功能减退大鼠抑郁行为明显，尤其是200μCi和400μCi组。3. RT-PCR结果表明在甲状腺功能减退时，脑纹状体D1DRmRNA表达是上调的，Western Blot实验结果与PCR结论一致，脑纹状体D1DR蛋白表达增加。
结论：1.200μCi放射性131I是建立甲状腺功能减退大鼠模型的最佳剂量，2周后即可成功建立甲状腺功能减退大鼠模型。2.甲状腺功能减退大鼠有抑郁行为存在。3.大鼠甲状腺功能减退伴发抑郁与脑纹状体多巴胺受体1表达的上调有关。
目的：了解甲状腺功能减退患者抑郁状态时SPECT脑多巴胺转运蛋白（DAT）显像。
方法：18例因甲状腺癌行甲状腺全切术，拟行放射性碘-131治疗而停用左旋甲状腺素4-6周的继发性甲状腺功能减退患者与10例甲状腺功能正常的健康成人对照。分别行蒙哥马利抑郁量表（MADR）和汉密尔顿抑郁量表（HRSD）问卷，行99mTc-TRODAT-1多巴胺转运蛋白显像计算双侧纹状体与小脑的放射性比值(ST/CB)进行比较。
结果：1.甲状腺功能减退组的MADRS和HRDS评分分别为19.44±8.07，19.83±7.49明显高于健康对照组（5.1±3.96，6.4±5.23），P值均<0.05。表明甲状腺功能减退病人存在明显抑郁。2.左右两侧纹状体/小脑比值（ST/CB）在正常对照组分别为1.61±0.05和1.615±0.06，在甲状腺功能减退组则分别为1.146±0.17和1.16±0.14，两组比较有明显统计学差异，提示甲状腺功能减退组两侧ST/CB比值明显降低。3.在正常对照组左右两侧ST/CB比值比较，P大于0.05，提示两侧ST/CB比值没有统计学差异。而甲状腺功能减退组左右两侧ST/CB比值比较，P小于0.05，提示在甲状腺功能减退组两侧分布均有统计学差异。
结论：1.甲状腺功能减退病人MADRS和HRDS抑郁量表评分均高于正常对照组，说明甲减伴发抑郁。2.甲状腺功能减退伴发抑郁时双侧纹状体与小脑的放射性比值（ST/CB）明显降低，表明多巴胺转运蛋白表达降低，提示脑纹状体多巴胺功能降低参与甲状腺减退伴抑郁的发病。
Objective: To observe depression behavior and striatal dopamine type-1receptor(D1DR) expression in hypothyroidism rats induced by different dose ofradioiodine-131.
Methods: Sprague-Dawley (SD) rats were treated with four different dosees ofradioiodine-131which were50μCi,100μCi,200μCi,400μCi respectively to get theadult hypothyrodisim rat models. Serum T3, T4and TSH and weights were measuredevery two weeks. Tail Suspension Test (TST) and Forced Swim Test (FST) were done atthe8th week and12cond week after radioiodine treatment to evaluate the depressivebehavior of the rats, and all the rats were killed after depressional experiments had beendone. D1DR expressions were determined by RT-PCR and West Blot.
Results: We didn’t get adult hypothyroidism models with50μCi radioiodine. Wesuccessful got hypothyroidism models with100μCi or more than100μCi radioiodine.TST and FST results indicated that hypothyroidism rats with obvious depressionbehaviors especially in200μCi and400μCi groups. RT-PCR results indicated thatD1DR mRNA in stratum were upregulated in hypothyroidism rats. Striatal D1DR protein were increased with Western Blot assay.
Conclusions:200μCi is an optimal dose for rat hypothyroidism model, and it onlytakes2weeks to successfully get the hypothyroidism models. Depressional behaviorsinduced by hypothyroidism, and this depression is associated with the upregulation ofD1DR in striatum.
Objective: To study brain stiatal dopamine transporters (DAT) SPECT imagingand depression in hypothyroidism patients.
Methods:18thyroid cancer patienst who had received total thyroidectomy andL-thyroxin were retreated for4-6weeks as the prepareation for radioiodine treatment asthe hypothyroidism patients and10healthy volunteers as control subjects were selected.Depression states in all the subjects were measured byHamilton Depression Rating Scale for Depression (HRSD) and Montgomery-sbergDepression Rating Scale (MADRS). Dopamine transporters (DAT) SPECT imagingswere conducted with99mTc-TRODAT-1. Bilateral striatum DAT specific uptakes of99mTc-TRODAT-1were calculated by the ratio of DAT uptake in striatum (ST) andcerellum (CB).
Results: MADRS and HRDS scores which were19.44±8.07and19.83±7.49respectively in hypothyroidism were significant higher than contral subjects which were 5.1±3.96and6.4±5.23respectively(P<0.05). These results indicated that obviousdepression in hypothyroism. The ratio of ST/CB in the right and left striatum were1.61±0.05and1.615±0.06respectively in control subjects, which is significant higherthan hypothyroidism patients which were1.146±0.17and1.16±0.14respectively(P<0.05). The ratio of ST/CB had significant difference between the rightand left striatum in hypothyroidism patients (P<0.05), but no significant difference inthe control subjects (P>0.05).
Conclusions: MADRS and HRDS scores in hypothyroidism are higher thancontrol subjects, and this indicates obvious depression in hypothyroidism. The ratio ofST/CB in bilateral striatum decreases in hypothyroidism patients, and this indicates thatDAT expressing decreased. Dopamine system function in brain striatum decreasingtakes part in the mechanism of depression in hypothyroidism.
方法：应用不同剂量（50μCi，100μCi，200μCi，400μCi）放射性131I处理健康Sprague-Dawley(SD)成年大鼠，获得成年甲状腺功能减退大鼠模型。于每两周测定血清T3，T4，TSH及体重，分别于第8周、12周行大鼠抑郁行为学实验：悬尾实验(Tail Suspension Test, TST)，强迫游泳实验(Forced Swim Test, FST)观察后处死，应用RT-PCR和Western blot方法观察脑纹状体D1DRmRNA及蛋白表达情况。
结果：1.50μCi放射性131I并不能成功获得甲状腺功能减退大鼠模型，而100μCi以上放射性131I可以诱导成功建立甲状腺功能减退大鼠模型。2.甲状腺功能减退大鼠抑郁行为学实验(TST和FST)表明甲状腺功能减退大鼠抑郁行为明显，尤其是200μCi和400μCi组。3. RT-PCR结果表明在甲状腺功能减退时，脑纹状体D1DRmRNA表达是上调的，Western Blot实验结果与PCR结论一致，脑纹状体D1DR蛋白表达增加。
结论：1.200μCi放射性131I是建立甲状腺功能减退大鼠模型的最佳剂量，2周后即可成功建立甲状腺功能减退大鼠模型。2.甲状腺功能减退大鼠有抑郁行为存在。3.大鼠甲状腺功能减退伴发抑郁与脑纹状体多巴胺受体1表达的上调有关。
目的：了解甲状腺功能减退患者抑郁状态时SPECT脑多巴胺转运蛋白（DAT）显像。
方法：18例因甲状腺癌行甲状腺全切术，拟行放射性碘-131治疗而停用左旋甲状腺素4-6周的继发性甲状腺功能减退患者与10例甲状腺功能正常的健康成人对照。分别行蒙哥马利抑郁量表（MADR）和汉密尔顿抑郁量表（HRSD）问卷，行99mTc-TRODAT-1多巴胺转运蛋白显像计算双侧纹状体与小脑的放射性比值(ST/CB)进行比较。
结果：1.甲状腺功能减退组的MADRS和HRDS评分分别为19.44±8.07，19.83±7.49明显高于健康对照组（5.1±3.96，6.4±5.23），P值均<0.05。表明甲状腺功能减退病人存在明显抑郁。2.左右两侧纹状体/小脑比值（ST/CB）在正常对照组分别为1.61±0.05和1.615±0.06，在甲状腺功能减退组则分别为1.146±0.17和1.16±0.14，两组比较有明显统计学差异，提示甲状腺功能减退组两侧ST/CB比值明显降低。3.在正常对照组左右两侧ST/CB比值比较，P大于0.05，提示两侧ST/CB比值没有统计学差异。而甲状腺功能减退组左右两侧ST/CB比值比较，P小于0.05，提示在甲状腺功能减退组两侧分布均有统计学差异。
结论：1.甲状腺功能减退病人MADRS和HRDS抑郁量表评分均高于正常对照组，说明甲减伴发抑郁。2.甲状腺功能减退伴发抑郁时双侧纹状体与小脑的放射性比值（ST/CB）明显降低，表明多巴胺转运蛋白表达降低，提示脑纹状体多巴胺功能降低参与甲状腺减退伴抑郁的发病。
Objective: To observe depression behavior and striatal dopamine type-1receptor(D1DR) expression in hypothyroidism rats induced by different dose ofradioiodine-131.
Methods: Sprague-Dawley (SD) rats were treated with four different dosees ofradioiodine-131which were50μCi,100μCi,200μCi,400μCi respectively to get theadult hypothyrodisim rat models. Serum T3, T4and TSH and weights were measuredevery two weeks. Tail Suspension Test (TST) and Forced Swim Test (FST) were done atthe8th week and12cond week after radioiodine treatment to evaluate the depressivebehavior of the rats, and all the rats were killed after depressional experiments had beendone. D1DR expressions were determined by RT-PCR and West Blot.
Results: We didn’t get adult hypothyroidism models with50μCi radioiodine. Wesuccessful got hypothyroidism models with100μCi or more than100μCi radioiodine.TST and FST results indicated that hypothyroidism rats with obvious depressionbehaviors especially in200μCi and400μCi groups. RT-PCR results indicated thatD1DR mRNA in stratum were upregulated in hypothyroidism rats. Striatal D1DR protein were increased with Western Blot assay.
Conclusions:200μCi is an optimal dose for rat hypothyroidism model, and it onlytakes2weeks to successfully get the hypothyroidism models. Depressional behaviorsinduced by hypothyroidism, and this depression is associated with the upregulation ofD1DR in striatum.
Objective: To study brain stiatal dopamine transporters (DAT) SPECT imagingand depression in hypothyroidism patients.
Methods:18thyroid cancer patienst who had received total thyroidectomy andL-thyroxin were retreated for4-6weeks as the prepareation for radioiodine treatment asthe hypothyroidism patients and10healthy volunteers as control subjects were selected.Depression states in all the subjects were measured byHamilton Depression Rating Scale for Depression (HRSD) and Montgomery-sbergDepression Rating Scale (MADRS). Dopamine transporters (DAT) SPECT imagingswere conducted with99mTc-TRODAT-1. Bilateral striatum DAT specific uptakes of99mTc-TRODAT-1were calculated by the ratio of DAT uptake in striatum (ST) andcerellum (CB).
Results: MADRS and HRDS scores which were19.44±8.07and19.83±7.49respectively in hypothyroidism were significant higher than contral subjects which were 5.1±3.96and6.4±5.23respectively(P<0.05). These results indicated that obviousdepression in hypothyroism. The ratio of ST/CB in the right and left striatum were1.61±0.05and1.615±0.06respectively in control subjects, which is significant higherthan hypothyroidism patients which were1.146±0.17and1.16±0.14respectively(P<0.05). The ratio of ST/CB had significant difference between the rightand left striatum in hypothyroidism patients (P<0.05), but no significant difference inthe control subjects (P>0.05).
Conclusions: MADRS and HRDS scores in hypothyroidism are higher thancontrol subjects, and this indicates obvious depression in hypothyroidism. The ratio ofST/CB in bilateral striatum decreases in hypothyroidism patients, and this indicates thatDAT expressing decreased. Dopamine system function in brain striatum decreasingtakes part in the mechanism of depression in hypothyroidism.
引文
[1] Mezosi E. Hyperthyroidism[J]. Orv Hetil.2006,147(28):1309-l314
[2] Constant E, Adam S, Seron X,et al. Anxiety and depression, attention,and executivefunctions in hypothyroidism[J]. J Int Neuropsychol Soc2005,11(5):535–44
[3] Fedotova J, Ordyan N. Involvement of D1receptors in depression-like behavior ofovariectomized rats[J]. Acta Physiol Hung.2011,98(2):165-76
[4] Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology ofdepression[J]. Arch. Gen.Psychiatry.2007,64:327–337
[5] Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry,2006,67(Suppl6):3–8
[6] Nowend KL, Arizzi M, Carlson BB, et al. D1or D2antagonism in nucleusaccumbens core or dorsomedial shell suppresses lever pressing for food but leads tocompensatory increases in chow consumption[J]. Pharmacol. Biochem. Behav.2001,69(3-4):373–382
[7] Kapur S, Mann JJ. Role of the dopaminergic system in depression[J]. Biol.Psychiatry.1992,32(1):1–17
[8] Roy A, Karoum F, Pollack S. Marked reduction in indexes of dopamine metabolismamong patients with depression who attempt suicide[J]. Arch. Gen. Psychiatry1992,49(6):447–450
[9] Vaccari A, Gessa G.[3H]tyramine binding: a comparison with neuronal
[3H]dopamine uptake and [3H]mazindol binding processes[J]. Neurochem Res.1989,14(10):949-55
[10] Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706
[11] Vaccari A，Stefanlni E， deMontisG，et al. Dopaminergic dysfunction in neonatalhypothyroidism: differential effects of GM1ganglioside[J]. NeuroPharmacology.1990,29(12):1161-1169
[12] Gottesfeld Z， Garcia CJ， Chronister RB. Perinatal，not adult，hypothyroidismsuppresses dopaminergic axon sprouting in the deafferented olfactory tubercle of adultrat [J].J Neurosei Res.1987,18(4):568-573
[13] Mezosi E. Hyperthyroidism[J]. Orv Hetil.2006,147(28):1309-l314
[14] Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs,the role of dopamine and norepinephrine in depression and antidepressant treatment[J].J. Clin. Psychiatry.2006,67(Suppl6):46–49
[15] Silverstone T. Response to bromocriptine distinguishes bipolar from unipolardepression[J]. Lancet.1984,1:903–904
[16] Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology ofdopamine receptors[J]. Pharmacol Rev.2011,63(1):182-217
[17] Fedotova J, Ordyan N. Involvement of D1receptors in depression-like behavior ofovariectomized rats[J]. Acta Physiol Hung.2011,98(2):165-176
[18] Noble RE: Depression in women[J]. Metab. Clin. Exp.2005,54(Supply1):49–42
[19]张黎.发育早期甲状腺功能减低与仔鼠脑内多巴胺D1类受体及成年期相关行为改变[D].浙江杭州：浙江大学，2010
[20] Bowden C, Theodorou A, Cheetham SC, et al. Dopamine D1and D2receptorbinding sites in brain samples from depressed suicides and controls[J]. Brain Res.1997,752(1-2):227–233
[21] Dougherty DD, Bonab AA, Ottowitz WE, et al. Decreased striatal D1binding asmeasured using PET and [11C]SCH23390in patients with major depression withanger attacks[J]. Depress Anxiety.2006,23(3):175–177
[22] Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[23] Sun Y, Zupan B, Raaka BM,et al. TRH-receptor-type-2-deficient mice areeuthyroid and exhibit increased depression and reduced anxiety phenotypes[J].Neuropsychopharmacology.2009,34(6):1601-8
[24] Zeng H, Schimpf BA, Rohde AD, et al. Thyrotropin-releasing hormone receptor1-deficient mice display increased depression and anxiety-like behavior[J]. MolEndocrinol.2007,21(11):2795-804
[25] Castagné V, Moser P, Porsolt RD. Behavioral Assessment of AntidepressantActivity in Rodents.In: Buccafusco JJ, editor. Methods of Behavior Analysis inNeuroscience.2nd edition. Boca Raton (FL): CRC Press;2009. Chapter6
[26] Ortega-Legaspi JM, de Gortari P, Garduno-Gutierrez R, et al. Expression of thedopaminergic D1and D2receptors in the anterior cingulate cortex in a model ofeuropathic pain[J].Mol Pain.2011,7(1):97
[27] Charney DS. Monoamine dysfunction and the pathophysiology and treatment ofdepression[J]. J.Clin.Psychiatry.1998,59(Supply14):11–14
[28] Engstrom G, Alling C, Blennow K, et al. Reduced cerebrospinalHVA concentrationand HVA/5-HIAA ratios in suicide attempters[J]. Eur Neuropsychopharmacol.1999,9(5):399-405
[29] Lambert G, Johansson M, Agren H, et al. Reduced brain norepinephrine anddopamine release in treatment-refractory depressive illness: evidence in support of thecatecholamine hypothesis of mood disorders[J]. Arch. Gen. Psychiatry.2000,57(8):787–793
[30] Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FaK,D (ed). Neuropsychopharmacology. The Fourth Generation of Progress[M]. New York:Raven Press,2000
[31] Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptoractivation[J]. Pharmacol Ther.2010,128(1):37-60
[32] Iversen SD, Iversen LL. Dopamine:50years in perspective[J]. Trends Neurosci.2007,30(5):188-93
[33] Ebert D, Feistel H, Loew T, et al. Dopamine and depressionFstriatal dopamine D2receptor SPECT before and after antidepressant therapy[J]. Psychopharmacology (Berl).1996,126(1):91–94
[34] Drevets W, Gadde K, Krishnan K. Neuroimaging studies of mood disorders. In:Charney D, Nestler E (eds). The Neurobiology of Mental Illness[M],2edn.2005
[35] Cannon DM, Klaver JM, Peck SA, et al. Dopamine type-1receptor binding inmajor depressive disorder assessed using positron emission tomography and
[11C]NNC-112[J]. Neuropsychopharmacology.2009,34(5):1277–1287
[36] Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients withmajor depressive disorder[J]. Int J Neuropsychopharmacol.2006,9(2):167–174
[37] Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1receptorgenes associated with bipolar I disorder[J]. Am J Med Genet B Neuropsychiatr Genet.2005,134B(1):37–38
[38] Oh-Nishi A，Saji M，Furudate SI，et al. Dopamine D(2)一like receptor funetion isconverted from excitatory to inhibitory by thyroxine in the developmentalhippocampus[J]. J Neuroendocrinol.2005,17(12):836-845
[39]Hosseini M, Dastghaib SS, Rafatpanah H, et al. Nitric oxide contributes to learningand memory deficits observed in hypothyroid rats during neonatal and juvenilegrowth[J]. Clinics (Sao Paulo).2010,65(11):1175-1181
[40]McAllister RM, Albarracin I, Price EM, et al. Thyroid status and nitric oxide in ratarterial vessels[J]. J Endocrinol.2005,185(1):111-119
[41]Quesada A, Sainz J, Wangensteen R,et al. Nitric oxide synthase activity inhyperthyroid and hypothyroid rats. Eur J Endocrinol.2002,147(1):117-22
[42]Reilly CP, Symons RG, Wellby ML. A rat model of the131I-induced changes inthyroid function[J]. J Endocrinol Invest.1986,9(5):367-70
[43]Johnson C, Olivier NB, Nachreiner R, et al. Effect of131I-induced hypothyroidismon indices of reproductive function in adult male dogs. J Vet Intern Med.1999,13(2):104-10.
[44]Pasteur I, Tronko N, Drozdovich I, et al. Xenotransplantation of cultured newbornpig thyroid tissue for the treatment of post-radioiodine hypothyroidism in rats[J].Cytotechnology.2000,33(1-3):89-92.
[45]Torlak V, Zemunik T, Modun D, et al.131I-induced changes in rat thyroid glandfunction. Braz J Med Biol Res.2007,40(8):1087-94
[46]da Costa VM, Moreira DG, Rosenthal D. Thyroid function and aging:gender-related differences[J].J Endocrinol.2001，171(1):193-8
[47]Soukup T, Zacharová G, Smerdu V,et al. Body, heart, thyroid gland and skeletalmuscle weight changes in rats with altered thyroid status[J].Physiol Res.2001，50(6):619-26
[48]Nowak KW, Kaczmarek P, Mackowiak P,et al. Rat thyroid gland expresses the longform of leptin receptors, and leptin stimulates the function of the gland in euthyroidnon-fasted animals[J].Int J Mol Med.2002,9(1):31-4
[49]Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive toantidepressant treatments[J].Nature.1977,266(5604):730-2
[50]Xiang L, Szebeni K, Szebeni A,et al. Dopamine receptor gene expression in humanamygdaloid nuclei: elevated D4receptor mRNA in major depression[J].Brain Res.2008,1207:214-24
[51]Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[52]Dugbartey AT. Neurocognitive aspects of hypothyroidism[J]. Arch Intern Med.1998,158(13):1413-8.
[53]Denicoff KD, Joffe RT, Lakshmanan MC, et al. Neuropsychiatric manifestations ofaltered thyroid state[J].Am J Psychiatry.1990,147(1):94-9
[54]Constant EL, Adam S, Seron X, et al. Anxiety and depression, attention, andexecutive functions in hypothyroidism[J]. J Int Neuropsychol Soc.2005,11(5):535-44
[55]Nagamachi S, Jinnouchi S, Nishii R,et al. Cerebral blood flow abnormalitiesinduced by transient hypothyroidism after thyroidectomy--analysis bytc-99m-HMPAO and SPM96[J]. Ann Nucl Med.2004,18(6):469-77
[56]Schraml FV, Beason-Held LL, Fletcher DW, et al. Cerebral accumulation of Tc-99methyl cysteinate dimer (ECD) in severe, transient hypothyroidism[J]. J Cereb BloodFlow Metab.2006,26(3):321-9
[57]Krausz Y, Freedman N, Lester H, et al. Brain SPECT study of common groundbetween hypothyroidism and depression[J]. Int J Neuropsychopharmacol.2007,10(1):99-106
[58]Kung HF, Kim JH, Kung MP, et al. Imaging of dopamine transporters in humanwith technetium-99m TRODAT-1[J]. Eur. J. Nucl. Med.23:1527-1530,1996
[59]Meltzer PC, Blundell P, Jones AG, et al. A technetium-99m SPECT imaging agentwhich targets the dopamine transporter in primate brain[J]. J. Med. Chem.40:1835-1844,1997
[60]Zoghbi SS, Tamagnan G, Baldwin RM, et al. Synthesis of a dopamine transporterbinding cyclopentadiene phenyltropane conjugate complexed with Re and99mTc[J].J. Nucl. Med.38:100p,1997
[61]罗蔚锋，包仕尧，吴锦昌等，99mTc-TRODAT-1SPECT多巴胺转运体显像对帕金森病早期诊断的价值[J]。中国神经精神疾病杂志.2001,27(2);106-108
[62]Shih MC, Hoexter MQ, Andrade LA, et al. Parkinson's disease and dopaminetransporter neuroimaging: a critical review[J].Sao Paulo Med J.2006,124(3):168-75
[63]Martins RC, Andersen ML, et al. Dopamine transporter regulation during fournights of REM sleep deprivation followed by recovery--an in vivo molecularimaging study in humans[J]. Sleep.2010,33(2):243-51
[64]Crits-Christoph P, Newberg A, Wintering N,et al. Dopamine transporter levels incocaine dependent subjects[J]. Drug Alcohol Depend.2008,98(1-2):70-6
[65]Montgomery SA, Asberg M. A new depression scale designed to be sensitive tochange[J].British J Psychiatry.1979,134:382-389
[66]Maier W, Philipp M, et al. Improving depression severity assessment–I. Reliability,internal validity and sensitivity to change of three observer depression scales[J]. JPsychiatr Res.1988,22:3-12
[67]胡平，陈玲，张海琴等，99mTc-TRODAT-1脑多巴胺转运体显像临床应用研究[J]。中山大学学报(医学科学版)2003,24(5):479-480,503
[68]Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter:immunochemical characterization and localization in brain[J]. J Neurosci.1995,15(3):1714-23
[69]Weintraub D, Newberg AB, Cary MS, et al. Striatal dopamine transporter imagingcorrelates with anxiety and depression symptoms in Parkinson's disease[J]. J NuclMed.2005,46(2):227-32
[70]Weng YH, Yen TC, Chen MC, et al. Sensitivity and specificity of99mTc-TRODAT-1SPECT imaging in differentiating patients with idiopathic
Parkinson's disease from healthy subjects[J].J Nucl Med.2004,45(3):393-401
[1]Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid diseaseprevalence study [J]. Arch Intern Med.2000,160(4):526-34
[2]Mezosi E. Hyperthyroidism[J]. Orv Hetil.2006,147(28):1309-l314
[3]Ahmad AM, Ahmad M, Young ET. Objective estimates of the probability ofdeveloping hypothyroidism following radioactive iodine treatment ofthyrotoxicosis[J]. Eur J Endocrinol.2002,146(6):767-775
[4]Chan S, Kiby MD. Thyroid hormone and central nervous system development[J].Journal of Endocrinology.2000,165(1):1-8
[5]Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in thedeveloping rat brain[J]. Thyroid.2003,13(11):1039-1056
[6]Koenig RJ. Thyroid hormone receptor coactivators and corepressors[J]. Thyroid.1998,8(8):703-71
[7]Yen PM. Physiological and molecular basis of thyroid hormone action[J].Physiological Reviews.2001,81(3):1097-1142
[8]Joffe RT, Marriott M. Thyroid hormone levels and recurrence of major depression[J].American Journal of Psychiatry.2000,157:1689-1691
[9] Hershman JM, Burman KD, Denke MA, et al. Subclinical thyroid disease-Scientificreview and guidelines for diagnosis and management[J]. JAMA.2004,291(2):228-238
[10]Madeira MD, Azevedo FP, Paula-Barbosa MM. Effects of long-termhypothyroidism in the morphology and synaptic organization of cerebellar ectopicgranule cells[J]. Histol Histopathol.1988,3:351-359
[11]Alva-Sanchez C, Ortiz-Butron R, Pacheco-Rosado J.Kainic acid does not affectCA3hippocampal region pyramidal cells in hypothyroid rats[J]. Brain ResearchBulletin2004,63:167-171
[12]Venero C, Guadano-Ferraz A, Herrero AI, et al. Anxiety, memory impairment, andlocomotor dysfunction caused by a mutant thyroid hormone receptor alpha1canbe ameliorated by T3treatment[J]. Genes&Development.2005,19:2152-2163
[13]Alva-Sancheza C, Sanchez-Huerta K, Arroyo-Helquera O,et al. The maintenance ofhippocampal pyramidal neuron populations is dependent on the modulation ofspecific cell cycle regulators by thyroid hormones[J]. Brain Research.2009,1271:27-35]
[14]Napoli R, Apuzzi V, Bosso G, et al. Recombinant Human Thyrotropin EnhancesEndothelial-Mediated Vasodilation of Conduit Arteries[J]. Journal of ClinicalEndocrinology&Metabolism.2009,94:1012-1016
[15]Erikci AA, Karagoz B, Ozturk A, et al. The effect of subclinical hypothyroidism onplatelet parameters.Hematology[J].2009,14:115-117
[16]Schlenker EH, Hora M, Liu Y, et al. Effects of thyroidectomy, T-4, and DITPAreplacement on brain blood vessel density in adult rats[J]. American Journal ofPhysiology-Regulatory Integrative and Comparative Physiology.2008,294:1504-1509
[17]Lass P, Slawek J, Derejko A, et al. Neurological and psychiatric disorders inthyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging[J].Minerva Endocrinologica.2008,33:75-84
[18]Kinuya S, Michigishi T, Tonami N, et al.Reversible cerebral hypoperfusionobserved with Tc-99m HMPAO SPECT in reversible dementia caused byhypothyroidism[J]. Clinical Nuclear Medicine.1999,24:666-668
[19]Constant EL, De Volder AG, Ivanoiu A, et al. Cerebral blood flow and glucosemetabolism in hypothyroidism: A positron emission tomography study[J]. Journalof Clinical Endocrinology and Metabolism.2001,86:3864-3870
[20]Nagamachi S, Jinnouchi S, Nishii R, et al. Cerebral blood flow abnormalitiesinduced by transient hypothyroidism after thyroidectomy–analysis bytc-99m-HMPAO and SPM96[J]. Ann Nucl Med.2004,18:469-477
[21]Krausz Y, Freedman N, Lester H,et al. Brain SPECT study of common groundbetween hypothyroidism and depression[J]. International Journal ofNeuropsychopharmacology.2007,10:99-106
[22]Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidlyprogressive dementia: Global hypoperfusion on SPECT scanning suggests apossible mechanism[J]. Neurology.1997,49:623-629
[23]Bauer M, Silverman DH, Schlagenhauf F, et al. Brain glucose metabolism inhypothyroidism: a positron emission tomography study before and after thyroidhormone replacement therapy[J]. J Clin Endocrinol Metab.2009,94:2922-2929
[24] Crisanti P, Omri B, Hughes EJ, et al. The expression of thyrotropin receptor in thebrain[J]. Endocrinology.2001,142:812-822
[25]Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs,the role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry.2006,67(Suppl6):46–49
[26]Silverstone T. Response to bromocriptine distinguishes bipolar from unipolardepression[J]. Lancet.1984,1:903–904
[27]Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology ofdepression[J]. Arch. Gen.Psychiatry.2007,64:327–337
[28]Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry,2006,67(Suppl6):3–8
[29]Nowend KL, Arizzi M, Carlson BB, et al. D1or D2antagonism in nucleusaccumbens core or dorsomedial shell suppresses lever pressing for food but leadsto compensatory increases in chow consumption[J]. Pharmacol. Biochem. Behav.2001,69(3-4):373–382
[30]Kapur S, Mann JJ. Role of the dopaminergic system in depression[J]. Biol.Psychiatry.1992,32(1):1–17
[31]Roy A, Karoum F, Pollack S. Marked reduction in indexes of dopamine metabolismamong patients with depression who attempt suicide[J]. Arch. Gen. Psychiatry1992,49(6):447–450
[32]Charney DS. Monoamine dysfunction and the pathophysiology and treatment ofdepression[J]. J.Clin.Psychiatry.1998,59(Supply14):11–14
[33]Vaccari A, Gessa G.[3H]tyramine binding: a comparison with neuronal
[3H]dopamine uptake and [3H]mazindol binding processes[J]. Neurochem Res.1989,14(10):949-55
[34]Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706.
[35]Engstrom G, Alling C, Blennow K, et al. Reduced cerebrospinalHVA concentrationand HVA/5-HIAA ratios in suicide attempters[J]. Eur Neuropsychopharmacol.1999,9(5):399-405
[36]Lambert G, Johansson M, Agren H, et al. Reduced brain norepinephrine anddopamine release in treatment-refractory depressive illness: evidence in support ofthe catecholamine hypothesis of mood disorders[J]. Arch. Gen. Psychiatry.2000,57(8):787–793
[37]Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FaK, D(ed). Neuropsychopharmacology. The Fourth Generation of Progress[M]. NewYork: Raven Press,2000
[38]Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptoractivation[J]. Pharmacol Ther.2010,128(1):37-60
[39]Iversen SD, Iversen LL. Dopamine:50years in perspective[J]. Trends Neurosci.2007,30(5):188-93
[40]Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology ofdopamine receptors[J]. Pharmacol Rev.2011,63(1):182-217
[41]Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients withmajor depressive disorder[J]. Int J Neuropsychopharmacol.2006,9(2):167–174
[42]Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1receptorgenes associated with bipolar I disorder[J]. Am J Med Genet B NeuropsychiatrGenet.2005,134B(1):37–38
[43]Bowden C, Theodorou A, Cheetham SC, et al. Dopamine D1and D2receptorbinding sites in brain samples from depressed suicides and controls[J]. Brain Res.1997,752(1-2):227–233
[44]Dougherty DD, Bonab AA, Ottowitz WE, et al. Decreased striatal D1binding asmeasured using PET and [11C]SCH23390in patients with major depression withanger attacks[J]. Depress Anxiety.2006,23(3):175–177
[45]Noble RE: Depression in women[J]. Metab. Clin. Exp.2005,54(Supply1):49–42
[46]Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[47]Xiang L, Szebeni K, Szebeni A, et al. Dopamine receptor gene expression in humanamygdaloid nuclei: elevated D4receptor mRNA in major depression[J]. Brain Res.2008,1207:214–224
[48]Ebert D, Feistel H, Loew T, et al. Dopamine and depressionFstriatal dopamine D2receptor SPECT before and after antidepressant therapy[J]. Psychopharmacology(Berl).1996,126(1):91–94
[49]Drevets W, Gadde K, Krishnan K. Neuroimaging studies of mood disorders. In:Charney D, Nestler E (eds). The Neurobiology of Mental Illness[M],2edn.2005
[50]Todd RD, Carl J, Harmon S, et al. Dynamic changes in striatal dopamine D2andD3receptor protein and mRNA in response to1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons[J]. JNeurosci.1996,16(23):7776–7782
[51]Cannon DM, Klaver JM, Peck SA, et al. Dopamine type-1receptor binding inmajor depressive disorder assessed using positron emission tomography and
[11C]NNC-112[J]. Neuropsychopharmacology.2009,34(5):1277–1287
[52]Gottesfeld Z， Garcia CJ， Chronister RB. Perinatal，not adult，hypothyroidismsuppresses dopaminergic axon sprouting in the deafferented olfactory tubercle ofadult rat [J].J Neurosei Res.1987,18(4):568-573
[53]Vaccari A，Stefanlni E， deMontisG，et al. Dopaminergic dysfunction in neonatalhypothyroidism: differential effects of GM1ganglioside[J]. NeuroPharmacology.1990,29(12):1161-1169
[54]Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706
[55]Oh-Nishi A，Saji M，Furudate SI，et al. Dopamine D(2)一like receptor funetion isconverted from excitatory to inhibitory by thyroxine in the developmentalhippocampus[J]. J Neuroendocrinol.2005,17(12):836-845
[56]. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrinemarker [J]. Psychoneuroendocrinology.1985,10(3).237-60
[57]Gupta S, Saha PK, Mukhopadhyay A. Prevalence of hypothyroidism andimportance of cholesterol estimation in patients suffering from major depressivedisorder[J]. J Indian Med Assoc.2008,106(4):240-242
[58]印海翔,钮伟芳.难治性抑郁症患者甲状腺激素水平的分析[J].神经疾病与精神卫生.2007,3:178-179
[2] Constant E, Adam S, Seron X,et al. Anxiety and depression, attention,and executivefunctions in hypothyroidism[J]. J Int Neuropsychol Soc2005,11(5):535–44
[3] Fedotova J, Ordyan N. Involvement of D1receptors in depression-like behavior ofovariectomized rats[J]. Acta Physiol Hung.2011,98(2):165-76
[4] Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology ofdepression[J]. Arch. Gen.Psychiatry.2007,64:327–337
[5] Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry,2006,67(Suppl6):3–8
[6] Nowend KL, Arizzi M, Carlson BB, et al. D1or D2antagonism in nucleusaccumbens core or dorsomedial shell suppresses lever pressing for food but leads tocompensatory increases in chow consumption[J]. Pharmacol. Biochem. Behav.2001,69(3-4):373–382
[7] Kapur S, Mann JJ. Role of the dopaminergic system in depression[J]. Biol.Psychiatry.1992,32(1):1–17
[8] Roy A, Karoum F, Pollack S. Marked reduction in indexes of dopamine metabolismamong patients with depression who attempt suicide[J]. Arch. Gen. Psychiatry1992,49(6):447–450
[9] Vaccari A, Gessa G.[3H]tyramine binding: a comparison with neuronal
[3H]dopamine uptake and [3H]mazindol binding processes[J]. Neurochem Res.1989,14(10):949-55
[10] Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706
[11] Vaccari A，Stefanlni E， deMontisG，et al. Dopaminergic dysfunction in neonatalhypothyroidism: differential effects of GM1ganglioside[J]. NeuroPharmacology.1990,29(12):1161-1169
[12] Gottesfeld Z， Garcia CJ， Chronister RB. Perinatal，not adult，hypothyroidismsuppresses dopaminergic axon sprouting in the deafferented olfactory tubercle of adultrat [J].J Neurosei Res.1987,18(4):568-573
[13] Mezosi E. Hyperthyroidism[J]. Orv Hetil.2006,147(28):1309-l314
[14] Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs,the role of dopamine and norepinephrine in depression and antidepressant treatment[J].J. Clin. Psychiatry.2006,67(Suppl6):46–49
[15] Silverstone T. Response to bromocriptine distinguishes bipolar from unipolardepression[J]. Lancet.1984,1:903–904
[16] Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology ofdopamine receptors[J]. Pharmacol Rev.2011,63(1):182-217
[17] Fedotova J, Ordyan N. Involvement of D1receptors in depression-like behavior ofovariectomized rats[J]. Acta Physiol Hung.2011,98(2):165-176
[18] Noble RE: Depression in women[J]. Metab. Clin. Exp.2005,54(Supply1):49–42
[19]张黎.发育早期甲状腺功能减低与仔鼠脑内多巴胺D1类受体及成年期相关行为改变[D].浙江杭州：浙江大学，2010
[20] Bowden C, Theodorou A, Cheetham SC, et al. Dopamine D1and D2receptorbinding sites in brain samples from depressed suicides and controls[J]. Brain Res.1997,752(1-2):227–233
[21] Dougherty DD, Bonab AA, Ottowitz WE, et al. Decreased striatal D1binding asmeasured using PET and [11C]SCH23390in patients with major depression withanger attacks[J]. Depress Anxiety.2006,23(3):175–177
[22] Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[23] Sun Y, Zupan B, Raaka BM,et al. TRH-receptor-type-2-deficient mice areeuthyroid and exhibit increased depression and reduced anxiety phenotypes[J].Neuropsychopharmacology.2009,34(6):1601-8
[24] Zeng H, Schimpf BA, Rohde AD, et al. Thyrotropin-releasing hormone receptor1-deficient mice display increased depression and anxiety-like behavior[J]. MolEndocrinol.2007,21(11):2795-804
[25] Castagné V, Moser P, Porsolt RD. Behavioral Assessment of AntidepressantActivity in Rodents.In: Buccafusco JJ, editor. Methods of Behavior Analysis inNeuroscience.2nd edition. Boca Raton (FL): CRC Press;2009. Chapter6
[26] Ortega-Legaspi JM, de Gortari P, Garduno-Gutierrez R, et al. Expression of thedopaminergic D1and D2receptors in the anterior cingulate cortex in a model ofeuropathic pain[J].Mol Pain.2011,7(1):97
[27] Charney DS. Monoamine dysfunction and the pathophysiology and treatment ofdepression[J]. J.Clin.Psychiatry.1998,59(Supply14):11–14
[28] Engstrom G, Alling C, Blennow K, et al. Reduced cerebrospinalHVA concentrationand HVA/5-HIAA ratios in suicide attempters[J]. Eur Neuropsychopharmacol.1999,9(5):399-405
[29] Lambert G, Johansson M, Agren H, et al. Reduced brain norepinephrine anddopamine release in treatment-refractory depressive illness: evidence in support of thecatecholamine hypothesis of mood disorders[J]. Arch. Gen. Psychiatry.2000,57(8):787–793
[30] Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FaK,D (ed). Neuropsychopharmacology. The Fourth Generation of Progress[M]. New York:Raven Press,2000
[31] Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptoractivation[J]. Pharmacol Ther.2010,128(1):37-60
[32] Iversen SD, Iversen LL. Dopamine:50years in perspective[J]. Trends Neurosci.2007,30(5):188-93
[33] Ebert D, Feistel H, Loew T, et al. Dopamine and depressionFstriatal dopamine D2receptor SPECT before and after antidepressant therapy[J]. Psychopharmacology (Berl).1996,126(1):91–94
[34] Drevets W, Gadde K, Krishnan K. Neuroimaging studies of mood disorders. In:Charney D, Nestler E (eds). The Neurobiology of Mental Illness[M],2edn.2005
[35] Cannon DM, Klaver JM, Peck SA, et al. Dopamine type-1receptor binding inmajor depressive disorder assessed using positron emission tomography and
[11C]NNC-112[J]. Neuropsychopharmacology.2009,34(5):1277–1287
[36] Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients withmajor depressive disorder[J]. Int J Neuropsychopharmacol.2006,9(2):167–174
[37] Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1receptorgenes associated with bipolar I disorder[J]. Am J Med Genet B Neuropsychiatr Genet.2005,134B(1):37–38
[38] Oh-Nishi A，Saji M，Furudate SI，et al. Dopamine D(2)一like receptor funetion isconverted from excitatory to inhibitory by thyroxine in the developmentalhippocampus[J]. J Neuroendocrinol.2005,17(12):836-845
[39]Hosseini M, Dastghaib SS, Rafatpanah H, et al. Nitric oxide contributes to learningand memory deficits observed in hypothyroid rats during neonatal and juvenilegrowth[J]. Clinics (Sao Paulo).2010,65(11):1175-1181
[40]McAllister RM, Albarracin I, Price EM, et al. Thyroid status and nitric oxide in ratarterial vessels[J]. J Endocrinol.2005,185(1):111-119
[41]Quesada A, Sainz J, Wangensteen R,et al. Nitric oxide synthase activity inhyperthyroid and hypothyroid rats. Eur J Endocrinol.2002,147(1):117-22
[42]Reilly CP, Symons RG, Wellby ML. A rat model of the131I-induced changes inthyroid function[J]. J Endocrinol Invest.1986,9(5):367-70
[43]Johnson C, Olivier NB, Nachreiner R, et al. Effect of131I-induced hypothyroidismon indices of reproductive function in adult male dogs. J Vet Intern Med.1999,13(2):104-10.
[44]Pasteur I, Tronko N, Drozdovich I, et al. Xenotransplantation of cultured newbornpig thyroid tissue for the treatment of post-radioiodine hypothyroidism in rats[J].Cytotechnology.2000,33(1-3):89-92.
[45]Torlak V, Zemunik T, Modun D, et al.131I-induced changes in rat thyroid glandfunction. Braz J Med Biol Res.2007,40(8):1087-94
[46]da Costa VM, Moreira DG, Rosenthal D. Thyroid function and aging:gender-related differences[J].J Endocrinol.2001，171(1):193-8
[47]Soukup T, Zacharová G, Smerdu V,et al. Body, heart, thyroid gland and skeletalmuscle weight changes in rats with altered thyroid status[J].Physiol Res.2001，50(6):619-26
[48]Nowak KW, Kaczmarek P, Mackowiak P,et al. Rat thyroid gland expresses the longform of leptin receptors, and leptin stimulates the function of the gland in euthyroidnon-fasted animals[J].Int J Mol Med.2002,9(1):31-4
[49]Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive toantidepressant treatments[J].Nature.1977,266(5604):730-2
[50]Xiang L, Szebeni K, Szebeni A,et al. Dopamine receptor gene expression in humanamygdaloid nuclei: elevated D4receptor mRNA in major depression[J].Brain Res.2008,1207:214-24
[51]Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[52]Dugbartey AT. Neurocognitive aspects of hypothyroidism[J]. Arch Intern Med.1998,158(13):1413-8.
[53]Denicoff KD, Joffe RT, Lakshmanan MC, et al. Neuropsychiatric manifestations ofaltered thyroid state[J].Am J Psychiatry.1990,147(1):94-9
[54]Constant EL, Adam S, Seron X, et al. Anxiety and depression, attention, andexecutive functions in hypothyroidism[J]. J Int Neuropsychol Soc.2005,11(5):535-44
[55]Nagamachi S, Jinnouchi S, Nishii R,et al. Cerebral blood flow abnormalitiesinduced by transient hypothyroidism after thyroidectomy--analysis bytc-99m-HMPAO and SPM96[J]. Ann Nucl Med.2004,18(6):469-77
[56]Schraml FV, Beason-Held LL, Fletcher DW, et al. Cerebral accumulation of Tc-99methyl cysteinate dimer (ECD) in severe, transient hypothyroidism[J]. J Cereb BloodFlow Metab.2006,26(3):321-9
[57]Krausz Y, Freedman N, Lester H, et al. Brain SPECT study of common groundbetween hypothyroidism and depression[J]. Int J Neuropsychopharmacol.2007,10(1):99-106
[58]Kung HF, Kim JH, Kung MP, et al. Imaging of dopamine transporters in humanwith technetium-99m TRODAT-1[J]. Eur. J. Nucl. Med.23:1527-1530,1996
[59]Meltzer PC, Blundell P, Jones AG, et al. A technetium-99m SPECT imaging agentwhich targets the dopamine transporter in primate brain[J]. J. Med. Chem.40:1835-1844,1997
[60]Zoghbi SS, Tamagnan G, Baldwin RM, et al. Synthesis of a dopamine transporterbinding cyclopentadiene phenyltropane conjugate complexed with Re and99mTc[J].J. Nucl. Med.38:100p,1997
[61]罗蔚锋，包仕尧，吴锦昌等，99mTc-TRODAT-1SPECT多巴胺转运体显像对帕金森病早期诊断的价值[J]。中国神经精神疾病杂志.2001,27(2);106-108
[62]Shih MC, Hoexter MQ, Andrade LA, et al. Parkinson's disease and dopaminetransporter neuroimaging: a critical review[J].Sao Paulo Med J.2006,124(3):168-75
[63]Martins RC, Andersen ML, et al. Dopamine transporter regulation during fournights of REM sleep deprivation followed by recovery--an in vivo molecularimaging study in humans[J]. Sleep.2010,33(2):243-51
[64]Crits-Christoph P, Newberg A, Wintering N,et al. Dopamine transporter levels incocaine dependent subjects[J]. Drug Alcohol Depend.2008,98(1-2):70-6
[65]Montgomery SA, Asberg M. A new depression scale designed to be sensitive tochange[J].British J Psychiatry.1979,134:382-389
[66]Maier W, Philipp M, et al. Improving depression severity assessment–I. Reliability,internal validity and sensitivity to change of three observer depression scales[J]. JPsychiatr Res.1988,22:3-12
[67]胡平，陈玲，张海琴等，99mTc-TRODAT-1脑多巴胺转运体显像临床应用研究[J]。中山大学学报(医学科学版)2003,24(5):479-480,503
[68]Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter:immunochemical characterization and localization in brain[J]. J Neurosci.1995,15(3):1714-23
[69]Weintraub D, Newberg AB, Cary MS, et al. Striatal dopamine transporter imagingcorrelates with anxiety and depression symptoms in Parkinson's disease[J]. J NuclMed.2005,46(2):227-32
[70]Weng YH, Yen TC, Chen MC, et al. Sensitivity and specificity of99mTc-TRODAT-1SPECT imaging in differentiating patients with idiopathic
Parkinson's disease from healthy subjects[J].J Nucl Med.2004,45(3):393-401
[1]Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid diseaseprevalence study [J]. Arch Intern Med.2000,160(4):526-34
[2]Mezosi E. Hyperthyroidism[J]. Orv Hetil.2006,147(28):1309-l314
[3]Ahmad AM, Ahmad M, Young ET. Objective estimates of the probability ofdeveloping hypothyroidism following radioactive iodine treatment ofthyrotoxicosis[J]. Eur J Endocrinol.2002,146(6):767-775
[4]Chan S, Kiby MD. Thyroid hormone and central nervous system development[J].Journal of Endocrinology.2000,165(1):1-8
[5]Anderson GW, Schoonover CM, Jones SA. Control of thyroid hormone action in thedeveloping rat brain[J]. Thyroid.2003,13(11):1039-1056
[6]Koenig RJ. Thyroid hormone receptor coactivators and corepressors[J]. Thyroid.1998,8(8):703-71
[7]Yen PM. Physiological and molecular basis of thyroid hormone action[J].Physiological Reviews.2001,81(3):1097-1142
[8]Joffe RT, Marriott M. Thyroid hormone levels and recurrence of major depression[J].American Journal of Psychiatry.2000,157:1689-1691
[9] Hershman JM, Burman KD, Denke MA, et al. Subclinical thyroid disease-Scientificreview and guidelines for diagnosis and management[J]. JAMA.2004,291(2):228-238
[10]Madeira MD, Azevedo FP, Paula-Barbosa MM. Effects of long-termhypothyroidism in the morphology and synaptic organization of cerebellar ectopicgranule cells[J]. Histol Histopathol.1988,3:351-359
[11]Alva-Sanchez C, Ortiz-Butron R, Pacheco-Rosado J.Kainic acid does not affectCA3hippocampal region pyramidal cells in hypothyroid rats[J]. Brain ResearchBulletin2004,63:167-171
[12]Venero C, Guadano-Ferraz A, Herrero AI, et al. Anxiety, memory impairment, andlocomotor dysfunction caused by a mutant thyroid hormone receptor alpha1canbe ameliorated by T3treatment[J]. Genes&Development.2005,19:2152-2163
[13]Alva-Sancheza C, Sanchez-Huerta K, Arroyo-Helquera O,et al. The maintenance ofhippocampal pyramidal neuron populations is dependent on the modulation ofspecific cell cycle regulators by thyroid hormones[J]. Brain Research.2009,1271:27-35]
[14]Napoli R, Apuzzi V, Bosso G, et al. Recombinant Human Thyrotropin EnhancesEndothelial-Mediated Vasodilation of Conduit Arteries[J]. Journal of ClinicalEndocrinology&Metabolism.2009,94:1012-1016
[15]Erikci AA, Karagoz B, Ozturk A, et al. The effect of subclinical hypothyroidism onplatelet parameters.Hematology[J].2009,14:115-117
[16]Schlenker EH, Hora M, Liu Y, et al. Effects of thyroidectomy, T-4, and DITPAreplacement on brain blood vessel density in adult rats[J]. American Journal ofPhysiology-Regulatory Integrative and Comparative Physiology.2008,294:1504-1509
[17]Lass P, Slawek J, Derejko A, et al. Neurological and psychiatric disorders inthyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging[J].Minerva Endocrinologica.2008,33:75-84
[18]Kinuya S, Michigishi T, Tonami N, et al.Reversible cerebral hypoperfusionobserved with Tc-99m HMPAO SPECT in reversible dementia caused byhypothyroidism[J]. Clinical Nuclear Medicine.1999,24:666-668
[19]Constant EL, De Volder AG, Ivanoiu A, et al. Cerebral blood flow and glucosemetabolism in hypothyroidism: A positron emission tomography study[J]. Journalof Clinical Endocrinology and Metabolism.2001,86:3864-3870
[20]Nagamachi S, Jinnouchi S, Nishii R, et al. Cerebral blood flow abnormalitiesinduced by transient hypothyroidism after thyroidectomy–analysis bytc-99m-HMPAO and SPM96[J]. Ann Nucl Med.2004,18:469-477
[21]Krausz Y, Freedman N, Lester H,et al. Brain SPECT study of common groundbetween hypothyroidism and depression[J]. International Journal ofNeuropsychopharmacology.2007,10:99-106
[22]Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidlyprogressive dementia: Global hypoperfusion on SPECT scanning suggests apossible mechanism[J]. Neurology.1997,49:623-629
[23]Bauer M, Silverman DH, Schlagenhauf F, et al. Brain glucose metabolism inhypothyroidism: a positron emission tomography study before and after thyroidhormone replacement therapy[J]. J Clin Endocrinol Metab.2009,94:2922-2929
[24] Crisanti P, Omri B, Hughes EJ, et al. The expression of thyrotropin receptor in thebrain[J]. Endocrinology.2001,142:812-822
[25]Nutt DJ, Baldwin DS, Clayton AH, et al. Consensus statement and research needs,the role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry.2006,67(Suppl6):46–49
[26]Silverstone T. Response to bromocriptine distinguishes bipolar from unipolardepression[J]. Lancet.1984,1:903–904
[27]Dunlop BW, Nemeroff CB. The role of dopamine in the pathophysiology ofdepression[J]. Arch. Gen.Psychiatry.2007,64:327–337
[28]Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressanttreatment[J]. J. Clin. Psychiatry,2006,67(Suppl6):3–8
[29]Nowend KL, Arizzi M, Carlson BB, et al. D1or D2antagonism in nucleusaccumbens core or dorsomedial shell suppresses lever pressing for food but leadsto compensatory increases in chow consumption[J]. Pharmacol. Biochem. Behav.2001,69(3-4):373–382
[30]Kapur S, Mann JJ. Role of the dopaminergic system in depression[J]. Biol.Psychiatry.1992,32(1):1–17
[31]Roy A, Karoum F, Pollack S. Marked reduction in indexes of dopamine metabolismamong patients with depression who attempt suicide[J]. Arch. Gen. Psychiatry1992,49(6):447–450
[32]Charney DS. Monoamine dysfunction and the pathophysiology and treatment ofdepression[J]. J.Clin.Psychiatry.1998,59(Supply14):11–14
[33]Vaccari A, Gessa G.[3H]tyramine binding: a comparison with neuronal
[3H]dopamine uptake and [3H]mazindol binding processes[J]. Neurochem Res.1989,14(10):949-55
[34]Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706.
[35]Engstrom G, Alling C, Blennow K, et al. Reduced cerebrospinalHVA concentrationand HVA/5-HIAA ratios in suicide attempters[J]. Eur Neuropsychopharmacol.1999,9(5):399-405
[36]Lambert G, Johansson M, Agren H, et al. Reduced brain norepinephrine anddopamine release in treatment-refractory depressive illness: evidence in support ofthe catecholamine hypothesis of mood disorders[J]. Arch. Gen. Psychiatry.2000,57(8):787–793
[37]Willner P. Dopaminergic mechanisms in depression and mania. In: Bloom FaK, D(ed). Neuropsychopharmacology. The Fourth Generation of Progress[M]. NewYork: Raven Press,2000
[38]Undieh AS. Pharmacology of signaling induced by dopamine D(1)-like receptoractivation[J]. Pharmacol Ther.2010,128(1):37-60
[39]Iversen SD, Iversen LL. Dopamine:50years in perspective[J]. Trends Neurosci.2007,30(5):188-93
[40]Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology ofdopamine receptors[J]. Pharmacol Rev.2011,63(1):182-217
[41]Koks S, Nikopensius T, Koido K, et al. Analysis of SNP profiles in patients withmajor depressive disorder[J]. Int J Neuropsychopharmacol.2006,9(2):167–174
[42]Severino G, Congiu D, Serreli C, et al. A48G polymorphism in the D1receptorgenes associated with bipolar I disorder[J]. Am J Med Genet B NeuropsychiatrGenet.2005,134B(1):37–38
[43]Bowden C, Theodorou A, Cheetham SC, et al. Dopamine D1and D2receptorbinding sites in brain samples from depressed suicides and controls[J]. Brain Res.1997,752(1-2):227–233
[44]Dougherty DD, Bonab AA, Ottowitz WE, et al. Decreased striatal D1binding asmeasured using PET and [11C]SCH23390in patients with major depression withanger attacks[J]. Depress Anxiety.2006,23(3):175–177
[45]Noble RE: Depression in women[J]. Metab. Clin. Exp.2005,54(Supply1):49–42
[46]Klimek V, Schenck JE, Han H, et al. Dopaminergic abnormalities in amygdaloidnuclei in major depression: a postmortem study[J]. Biol. Psychiatry.2002,52(7):740–748
[47]Xiang L, Szebeni K, Szebeni A, et al. Dopamine receptor gene expression in humanamygdaloid nuclei: elevated D4receptor mRNA in major depression[J]. Brain Res.2008,1207:214–224
[48]Ebert D, Feistel H, Loew T, et al. Dopamine and depressionFstriatal dopamine D2receptor SPECT before and after antidepressant therapy[J]. Psychopharmacology(Berl).1996,126(1):91–94
[49]Drevets W, Gadde K, Krishnan K. Neuroimaging studies of mood disorders. In:Charney D, Nestler E (eds). The Neurobiology of Mental Illness[M],2edn.2005
[50]Todd RD, Carl J, Harmon S, et al. Dynamic changes in striatal dopamine D2andD3receptor protein and mRNA in response to1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons[J]. JNeurosci.1996,16(23):7776–7782
[51]Cannon DM, Klaver JM, Peck SA, et al. Dopamine type-1receptor binding inmajor depressive disorder assessed using positron emission tomography and
[11C]NNC-112[J]. Neuropsychopharmacology.2009,34(5):1277–1287
[52]Gottesfeld Z， Garcia CJ， Chronister RB. Perinatal，not adult，hypothyroidismsuppresses dopaminergic axon sprouting in the deafferented olfactory tubercle ofadult rat [J].J Neurosei Res.1987,18(4):568-573
[53]Vaccari A，Stefanlni E， deMontisG，et al. Dopaminergic dysfunction in neonatalhypothyroidism: differential effects of GM1ganglioside[J]. NeuroPharmacology.1990,29(12):1161-1169
[54]Vaceari A， Rossetti ZL， de Montis G，et al. Neonatal hypothyroidism inducesstriatal dopaminergic dysfunction[J].Neuroseience.1990,35(3):699-706
[55]Oh-Nishi A，Saji M，Furudate SI，et al. Dopamine D(2)一like receptor funetion isconverted from excitatory to inhibitory by thyroxine in the developmentalhippocampus[J]. J Neuroendocrinol.2005,17(12):836-845
[56]. The TRH-induced TSH response in psychiatric patients: a possible neuroendocrinemarker [J]. Psychoneuroendocrinology.1985,10(3).237-60
[57]Gupta S, Saha PK, Mukhopadhyay A. Prevalence of hypothyroidism andimportance of cholesterol estimation in patients suffering from major depressivedisorder[J]. J Indian Med Assoc.2008,106(4):240-242
[58]印海翔,钮伟芳.难治性抑郁症患者甲状腺激素水平的分析[J].神经疾病与精神卫生.2007,3:178-179